Member Info for Soupdragon78

Looking like they've churned out the sellers.

Its a shame Offshore decided to leave this site and his twitter before this news. He wasn't a fan of Oxilio but would have been glad of the sp rise I'm sure.

I'm amazed we haven't seen a TR1 for AC or DT after the churn of the placing, would be bonkers if they haven't used the recent volume to sell up.

Exactly FX, so now they negotiate the license for NXP001, the placing money that was allocated to that is freed up to develop other lines further.
We will hear news on the NXP001 license, as well as the Innovate Grant and also the development of NXP004 which is targetting being sold back to the global player whose multi-billion drug it is improving and extending the patent.

And then we hit the inflection points for NXP002 in Q3.

Patience.

The volume shows sellers are just those who bought for a quick buck on Friday.

Next news could be very soon and Allenby will also update their valuation.

There we go. Oxilio have exercised their option

Interesting that Oxilio added additional NFX info to their website last night.

Exactly Abman, NFX have acted as consultants to Oxilio for the period of their evaluation, so should know what the status of their interest is.

FX, remember Oxilio only need to take up their option before 23rd. Once they have done so they will begin a negotiation with NFX as to the terms of the license.
Oxilio only started an open fund raise at the end of Feb / beginning of March, so they need to be in a place to be confident of their resources prior to negotiations commencing, understandably they will take that to a late point, which may have been a closing of the funding on Friday just gone. Then they can sign off their option on Monday and commence negotiating.

It was interesting that in the half years that Blackwell wrote in December, it mentioned that they would update on Oxilio in H1 2021, but when Anne gave her update she was right onto the 23rd deadline, putting the pressure back on them.

Stockvirgin, you have enough problems with the scam that is UKOG to worry yourself about what is happening here.

UQ, you might want to get in touch with the company broker Allenby, you valuation is way higher than theirs.

Well done Filter.

A close above 3p would be very good. Just need it to hang on for the next 40mins.

Very pleased to see continuation this afternoon on large volume.

Good to see its got legs.

Great to see the volume here, above and beyond the reach of the twitter crowd so feels like something substantial happening.

Looks leaky, good volume

Indeed Hale, it could possible have benefits in more ‘day to day’ inhaler use such as asthma etc.

They still need to do the feasibility though to test out the delivery.

Twist, the two patents are available to view online. They are waiting on the granting of patent WO2020035546 - CRYSTALLINE TRANILAST SALTS AND THEIR PHARMACEUTICAL USE

This covers all tranilast cocrystals and their uses.

Hale, generic tranilast is readily available in Asia and used typically in eye drops. NFX inhaled type will open up a different market but won’t cover its current use.

Strange that twitter folk are obsessed that AstraZeneca used to be on the same business park as NFX, even though they are headquartered in Royston and the new Addenbrooks site is nearly ready.

Not looking to get back in at the moment Scary, I'm happy with my holding and my decision to take some money out.